Simcere Pharmaceutical Group Limited — Board/Management Information 2021

Jun 30, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [44 x 34] intentionally omitted <==

Simcere Pharmaceutical Group Limited 先聲藥業集團有限公司

(Incorporated in Hong Kong with limited liability)

(Stock code: 2096)

RESIGNATION OF JOINT COMPANY SECRETARY

The board of directors (the “ Board ”) of Simcere Pharmaceutical Group Limited (the “ Company ”) hereby announces that, Ms. Feng Jie (“ Ms. Feng ”) has tendered her resignation as the Joint Company Secretary of the Company with effect from June 30, 2021.

Ms. Feng confirmed that she has no disagreement with the Board and that there is no matter in relation to her resignation that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”) and the shareholders of the Company.

After the resignation of Ms. Feng as the Joint Company Secretary of the Company, Mr. Bao Jun, the secretary to the Board, and Ms. Mak Po Man Cherie, who meets the requirement under Rules 3.28 and 8.17 of the Rules Governing the Listing of Securities on the Stock Exchange (the “ Listing Rules ”), currently the other Joint Company Secretaries of the Company, will remain as the Joint Company Secretaries of the Company and will continue to perform and discharge the duties of a company secretary under the Listing Rules.

The Board would like to take this opportunity to express its sincere gratitude to Ms. Feng for her invaluable contribution to the Company during her tenure of service.

By order of the Board of Simcere Pharmaceutical Group Limited Mr. Ren Jinsheng Chairman and Chief Executive Officer

Hong Kong, June 30, 2021

As at the date of this announcement, the Board comprises Mr. REN Jinsheng as the Chairman and executive Director, Mr. WAN Yushan and Mr. TANG Renhong as the executive Directors; Mr. ZHAO John Huan as the non-executive Director; and Mr. SONG Ruilin, Mr. WANG Jianguo and Mr. WANG Xinhua as the independent non-executive Directors.